Pralatrexate (10-propargyl-10-deazaaminopterin (PRX)), a novel antifolate, effects durable complete remissions (CR) in patients with a diversity of drug resistant T-cell lymphomas with minimal toxicity Meeting Abstract
| Authors: | O'connor, O.; Hamlin, P. A.; Neylon, E.; Moskowitz, C.; Portlock, C. S.; Straus, D. J.; Noy, A.; Cortelli, B.; Zelenetz, A. D.; Fleisher, M.; Sarasohn, D.; Sirotnak, F. M.; Horwitz, S. |
| Abstract Title: | Pralatrexate (10-propargyl-10-deazaaminopterin (PRX)), a novel antifolate, effects durable complete remissions (CR) in patients with a diversity of drug resistant T-cell lymphomas with minimal toxicity |
| Meeting Title: | 47th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 106 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2005 Dec 10-13 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2005-11-01 |
| Start Page: | 752A |
| Language: | English |
| ACCESSION: | WOS:000233426004525 |
| PROVIDER: | wos |
| PUBMED: | 16342400 |
| DOI: | 10.1182/blood.V106.11.2678.2678 |
| Notes: | --- - Meeting Abstract: 2678 - 47th Annual Meeting of the American-Society-of-Hematology - DEC 10-13, 2005 - Atlanta, GA - "1" - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work